News Releases
Aug 14, 2024
Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Additional Formats
May 21, 2024
Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital
Additional Formats
May 06, 2024
Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis
Additional Formats
Apr 30, 2024
Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Additional Formats
Apr 26, 2024
Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Additional Formats
Mar 21, 2024
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Additional Formats
Mar 01, 2024
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Additional Formats